Bax Inhibitor-1 regulates hepatic lipid accumulation via ApoB secretion

  • Hwa Young Lee
  • , Geum Hwa Lee
  • , Kashi Raj Bhattarai
  • , Byung Hyun Park
  • , Seung Hoi Koo
  • , Hyung Ryong Kim
  • , Han Jung Chae*
  • *Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    15 Citations (Scopus)

    Abstract

    In this study, we explored the effects of Bax Inhibitor-1 (BI-1) on ApoB aggregation in high-fat diet (HFD)-induced hepatic lipid accumulation. After 1 week on a HFD, triglycerides and cholesterol accumulated more in the liver and were not effectively secreted into the plasma, whereas after 8 weeks, lipids were highly accumulated in both the liver and plasma, with a greater effect in BI-1 KO mice compared with BI-1 WT mice. ApoB, a lipid transfer protein, was accumulated to a greater extent in the livers of HFD-BI-1 KO mice compared with HFD-BI-1 WT mice. Excessive post-translational oxidation of protein disulfide isomerase (PDI), intra-ER ROS accumulation and folding capacitance alteration were also observed in HFD-BI-1 KO mice. Higher levels of endoplasmic reticulum (ER) stress were consistently observed in KO mice compared with the WT mice. Adenovirus-mediated hepatic expression of BI-1 in the BI-1 KO mice rescued the above phenotypes. Our results suggest that BI-1-mediated enhancement of ApoB secretion regulates hepatic lipid accumulation, likely through regulation of ER stress and ROS accumulation.

    Original languageEnglish
    Article number27799
    JournalScientific reports
    Volume6
    DOIs
    Publication statusPublished - 2016 Jun 14

    Bibliographical note

    Funding Information:
    This study was supported by the National Research Foundation (2015R1A2A1A13001849 and 2008-0062279).

    ASJC Scopus subject areas

    • General

    Fingerprint

    Dive into the research topics of 'Bax Inhibitor-1 regulates hepatic lipid accumulation via ApoB secretion'. Together they form a unique fingerprint.

    Cite this